|
Dear Shareholders,
This is a special CEO
update to provide news related to our
HeartCheck™ sales and marketing efforts. Please
find attached a copy of a Letter of Intent (LOI) provided under the approval of McKesson Canada,
Specialty Division (McKesson). The LOI is
self-explanatory.
As stated by CardioComm
Solutions over the past few months, we have been
working diligently to place the HeartCheck™ PEN
and the SMART Monitoring ECG service into
pharmacies in Canada. Pharmacies are a
very appropriate setting for the recommended use
of an ECG screening solution, performed by
pharmacists, on persons who are at risk for
arrhythmia based cardiac diseases.
In October we initiated
an aggressive marketing campaign which began
with the launch of a CBC circulated TV
commercial and the placement of HeartCheck™ PEN
devices into pharmacies in Southern Ontario
under the Total Health and Remedy’sRx pharmacy
banner groups. In November and December we have
been scheduling the setup of the HeartCheck
Partner Program in these pharmacies. While doing
so, we have also continued to look at additional
and larger pharmacy banner groups.
We view this LOI to be
an important milestone in our efforts of
expanding HeartCheck™ ECG screening and
monitoring services into the consumer market.
We have worked hard to secure independent
regulatory and clinical validation of our
technologies, and are now focused on the sales
and implementation of the HeartCheck™ PEN and
SMART Monitoring ECG screening services into
pharmacies and other verticals globally.
We are grateful to have
been permitted to share this update with our
shareholders. Details regarding the project will
be disclosed at a later date and any press
releases will be made in accordance with
non-disclosure details that are currently in
place.
More information
regarding the HeartCheck™ products and SMART
monitoring solutions is available at the
Company’s website www.theheartcheck.com.
This release may
contain certain forward-looking statements
with respect to the financial condition,
results of operations and business of
CardioComm Solutions and certain of the plans
and objectives of CardioComm Solutions with
respect to these items. By their nature,
forward-looking statements involve risk and
uncertainty because they relate to events and
depend on circumstances that will occur in the
future and there are many factors that could
cause actual results and developments to
differ materially from those expressed or
implied by these forward-looking statements.
|
